RADIAN® - Working Together to end HIV in Eastern Europe and Central Asia
RADIAN funds innovative, community-led HIV prevention and care programs in Eastern Europe and Central Asia to reduce infections and deaths through new models, education, and empowerment.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (application deadline, projected)
Funding Amounts: Significant funding for Model Cities and local initiatives; multiple funding streams available; typical award amounts not specified.
Summary: Collaborative initiative supporting innovative, community-led HIV prevention and care programs in Eastern Europe and Central Asia.
Key Information: This is a forecasted opportunity; dates and details may change—monitor program page for updates.
Description
RADIAN is a partnership between Gilead Sciences and the Elton John AIDS Foundation aimed at addressing the escalating HIV crisis in Eastern Europe and Central Asia (EECA). The initiative seeks to reduce new HIV infections and AIDS-related deaths by supporting innovative, community-driven prevention and care models. RADIAN provides major funding through several mechanisms:
- Model Cities: Substantial support for new models of care and expanded prevention programs in key EECA cities, starting with Almaty, Kazakhstan and expanding to other high-need locations.
- Unmet Need Fund: Grants to local initiatives across EECA focused on education, empowerment, prevention, and new partnerships.
- New Funding Streams (from 2025): Including the Innovation Challenge Fund, Equity Challenge Fund, and Success Replication Fund to foster novel solutions, address root causes, and scale proven interventions.
The program emphasizes community empowerment, stigma reduction, and improved access to care for populations most affected by HIV.
